Navigation Links
CHPA Lends Support to FDA's Announcement Against Use of Oral, Over-the-Counter Cough and Cold Medicines in Children Under Two
Date:1/17/2008

Agency's announcement underscores industry's voluntary withdrawal of oral

infant cough and cold medicines in October 2007

WASHINGTON, Jan. 17 /PRNewswire/ -- On behalf of the leading makers of over-the-counter (OTC) cough and cold medicines, the Consumer Healthcare Products Association (CHPA) offered its support for today's U.S. Food and Drug Administration (FDA) decision against the use of oral OTC cough and cold medicines in children under the age of two. The agency's recommendation reaffirms the October 2007 action by the leading makers of pediatric OTC medicines' to voluntarily withdraw "infant" oral cough and cold medicines for children under the age of two.

"Safety has always been and continues to be our top priority," said Linda A. Suydam, D.P.A, president of CHPA. "Last fall, the leading makers of OTC, oral cough and cold medicines for infants voluntarily withdrew these medicines out of concern that their potential misuse could lead to possible overdose among very young children. While CHPA and its member companies believe that the large majority of parents and caregivers know how to safely and appropriately administer these medicines, and that they are safe when taken as directed, we took this voluntary action recognizing that infants are especially vulnerable to accidental misuse."

"Today's decision by FDA reaffirms the correct course of action taken by the leading makers of these medicines last fall," Suydam added. "Since then, we have been working with the retail community, healthcare professionals and FDA officials to ensure that parents have the tools they need to safely and appropriately administer OTC oral cough and cold medicines to children over the age of two. We have already begun a new educational campaign for parents and caregivers of small children, and remain intent on ensuring that parents have access to the very best OTCs for their families, as well as accurate information about safe and appropriate OTC cough and cold medicine use in children."

Helpful tips for parents and caregivers can be found at http://www.OTCsafety.org/Parents.

CHPA is the 127-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplement products.
http://www.chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. COLORBLENDS to Donate Portion of Sales of Spring Forward Daffodil Blend to the Christopher and Dana Reeve Foundation
2. HIV therapy in pregnancy-data support WHO recommendations
3. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
4. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
5. Family-based treatment more effective than supportive psychotherapy in treating bulimia
6. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
7. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
8. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
9. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
10. Hundreds of MADD Supporters Meet in St. Louis on Sept. 6-8
11. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 2017 , ... Contrary to popular perception, a new study ... noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues found a 29% ... United States. The study, Trends in Fighting and Violence Among Adolescents in ...
(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... performance system, has partnered with O2X , an active lifestyle company that ... on improving the health of firefighters, police offers, first responders, military officers and ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... Abilene, Texas (PRWEB) , ... April 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... out to world leaders in hopes of squashing a global crisis with solution to peace ... is guaranteed to work because the plan is given by the Creator Himself. , ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/18/2017)... Ohio , April 18, 2017  Cardinal Health ... Non-GAAP 1 fiscal 2017 earnings per share (EPS) ... and 2019.  This is in conjunction with this morning,s ... Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... from continuing operations will be at the bottom of ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: